ChemicalBook > Product Catalog >API >Circulatory system drugs >Antihypertensive drugs >DIAZOXIDE

DIAZOXIDE

DIAZOXIDE Structure
CAS No.
364-98-7
Chemical Name:
DIAZOXIDE
Synonyms
hyperstat;Proglycem;Eudemine;Sch-6783;mutabase;srg95213;dizoxide;diazoxid;NSC-64198;proglicem
CBNumber:
CB8426893
Molecular Formula:
C8H7ClN2O2S
Molecular Weight:
230.67
MOL File:
364-98-7.mol
Modify Date:
2024/7/2 8:55:32

DIAZOXIDE Properties

Melting point >310°C
Boiling point 414.8±47.0 °C(Predicted)
Density 1.3767 (rough estimate)
refractive index 1.6300 (estimate)
storage temp. 2-8°C
solubility 0.1 M NaOH: soluble
form Solid
pka pKa 8.5 (Uncertain)
color White
Water Solubility Soluble in 0.1M NaOH. Insoluble in water or in methanol.
λmax 268nm(MeOH)(lit.)
Merck 14,3004
Stability Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P264-P270-P301+P312-P302+P352-P305+P351+P338
Hazard Codes  Xn
Risk Statements  22-36/37/38
Safety Statements  22-26-36
WGK Germany  3
RTECS  DK8185000
HS Code  2934990002
NFPA 704
0
2 0

DIAZOXIDE price More Price(5)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) D9035 Diazoxide 364-98-7 250MG ₹9612.6 2022-06-14 Buy
Sigma-Aldrich(India) D9035 Diazoxide 364-98-7 1G ₹30948.68 2022-06-14 Buy
Sigma-Aldrich(India) D9035 Diazoxide 364-98-7 5G ₹98962.15 2022-06-14 Buy
TCI Chemicals (India) D5402 Diazoxide 364-98-7 250MG ₹2700 2022-05-26 Buy
TCI Chemicals (India) D5402 Diazoxide 364-98-7 1G ₹10500 2022-05-26 Buy
Product number Packaging Price Buy
D9035 250MG ₹9612.6 Buy
D9035 1G ₹30948.68 Buy
D9035 5G ₹98962.15 Buy
D5402 250MG ₹2700 Buy
D5402 1G ₹10500 Buy

DIAZOXIDE Chemical Properties,Uses,Production

Description

Diazoxide is a nondiuretic derivative of thiazides that dramatically reduces blood pressure by direct relaxation of smooth muscles of the arterioles, possibly as a result of calcium channel activation of smooth musculature in arterioles. It has a weak effect on the venous system and on the heart. In addition to hypotensive action, diazoxide causes a sharp increase in the level of glucose in the blood as a result of the inhibition of insulin release from adrenal glands. Some of the undesirable effects are water and sodium ion retention in the body and increased concentrations of uric acid in the blood. It is used in urgent situations where blood pressure needs to be reduced in severe hypertension. Diazoxide is not used for essential hypertension. A synonym of this drug is hyperstat.

Chemical Properties

White Solid

Uses

Diazoxide reduces status epilepticus neuron damage in diabetes.

Definition

ChEBI: A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the oncentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.

Biological Functions

Diazoxide (Hyperstat) is chemically similar to the thiazide diuretics. It is devoid of diuretic activity and causes Na+ and water retention. Diazoxide is a very potent vasodilator and is available only for intravenous use in the treatment of hypertensive emergencies. The mechanism by which diazoxide relaxes vascular smooth muscle is related to its ability to activate potassium channels and produce a hyperpolarization of the cell membrane.

General Description

Diazoxide is 7-chloro-3-methyl-4H-benzo[e][1,2,4]thiadiazine-1,1-dioxide , and is currentlyavailable in the United States only as a 50-mg/mLoral suspension (Proglycem); discontinued formulations includedcapsules for oral administration, and injectable formsthat typically found use for indications other than hypoglycemicconditions. Diazoxide is a cyclic benzenesulfonamide,although the free acid in solution can exist in threetautomeric forms, and the 4H tautomer most likely predominatesto a very high proportion. Partly because of theadditional nitrogen in the quinazoline ring structure, themolecule is somewhat more acidic (pKa~8.4, 8.6)than benzenesulfonamide (pKa~10).

Biological Activity

Antihypertensive, activates ATP-dependent K + channels. Induces activation of PKC ε , an intermediate in the opening of mitoK ATP channels, results in cardioprotection against hypoxia-induced death. Blocks desensitization of AMPA receptors.

Pharmacokinetics

Following rapid IV administration, diazoxide produces a prompt reduction in blood pressure, with maximum hypotensive effects occurring within 5 minutes. The duration of its hypotensive effect varies from 3 to 12 hours, but ranges from 30 minutes to 72 hours have been observed. The elimination half-life of diazoxide following a single oral or IV dose has been reported to range from 21 to 45 hours in adults with normal renal function. In patients with renal impairment, the half-life is prolonged. Approximately 90% of the diazoxide in the blood is bound to plasma proteins. Approximately 20 to 50% of diazoxide is eliminated unchanged in the urine, along with its major metabolites, resulting from the oxidation of the 3-methyl group to its 3-hydroxymethyl- and 3-carboxyl-metabolites.

Pharmacology

The hemodynamic effects of diazoxide are similar to those of hydralazine and minoxidil. It produces direct relaxation of arteriolar smooth muscle with little effect on capacitance beds. Since it does not impair cardiovascular reflexes, orthostasis is not a problem. Its administration is, however, associated with a reflex increase in cardiac output that partially counters its antihypertensive effects. Propranolol and other -blockers potentiate the vasodilating properties of the drug. Diazoxide has no direct action on the heart. Although renal blood flow and glomerular filtration may fall transiently, they generally return to predrug levels within an hour.

Clinical Use

Diazoxide is used by intravenous injection as a rapidly acting antihypertensiveagent for emergency reduction of blood pressurein hospitalized patients with accelerated or malignanthypertension. More than 90% is bound to serum protein, andcaution is needed when it is used in conjunction with otherprotein-bound drugs that may be displaced by diazoxide.The injection is given rapidly by the intravenous route toensure maximal effect. The initial dose is usually 1 mg/kg ofbody weight, with a second dose given if the first injectiondoes not lower blood pressure satisfactorily within 30 minutes.Further doses may be given at 4- to 24-hour intervalsif needed. Oral antihypertensive therapy is begun as soon aspossible.

Side effects

Since diazoxide is not often used for long-term treatment, toxicities associated with chronic use are rare.The chief concern is the side effects associated with the increased workload on the heart, which may precipitate myocardial ischemia and Na+ and water retention. These undesirable effects can be controlled by concurrent therapy with a β-blocker and a diuretic.
Diazoxide may cause hyperglycemia, especially in diabetics, so if the drug is used for several days, blood glucose levels should be measured. When used in the treatment of toxemia, diazoxide may stop labor, because it relaxes uterine smooth muscle.

Environmental Fate

Diazoxide is a potassium channel activator, which causes local relaxation in smooth muscles by increasing membrane permeability to potassium ions. Consequently, voltage-gated calcium ion channels are ineffective, inhibiting the generation of an action potential. The primary mechanism by which diazoxide lowers blood pressure is by direct relaxation of medium sized blood vessels. The cardiac output and renin secretion increases, resulting in elevated angiotensin II levels and retention of salt and water. When used to treat low blood sugar, diazoxide decreases insulin release from the pancreas.

Metabolism

Diazoxide lowers blood pressure within 3 to 5 minutes after rapid intravenous injection, and its duration of action may be 4 to 12 hours. Interestingly, if diazoxide is either injected slowly or infused its hypotensive action is quite modest.This is believed to be due to a rapid and extensive binding of the drug to plasma proteins. Both the liver and kidney contribute to its metabolism and excretion.The plasma half-life is therefore prolonged in patients with chronic renal failure.

DIAZOXIDE Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 238)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
AnalyticsStanza Inc +91-7032031309 +91-7032031309 Hyderabad, India 227 58 Inquiry
CHEMAZON LABORATORIES +91 9848551964 Hyderabad, India 1320 58 Inquiry
Nuray Chemicals Pvt Ltd +91-4066616700 +91-8220444745 Tamil Nadu, India 49 58 Inquiry
Aruvi Labs +91-8056181939 +91-8056181939 Tamil Nadu, India 149 58 Inquiry
Biophore India Pharmaceuticals Pvt Ltd +91-9100031592 +91-9030907714 Telangana, India 134 58 Inquiry
MSN LABORATORIES PRIVATE LTD +91 40 30438600 New Delhi, India 230 58 Inquiry
BIOPHORE INDIA PHARMACEUTICALS PVT LTD +91-4047474545 New Delhi, India 105 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
TCI Chemicals (India) Pvt. Ltd. 1800 425 7889 New Delhi, India 6778 58 Inquiry

Related articles

  • Efficacy and safety of Diazoxide
  • Diazoxide is a benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuret....
  • Feb 16,2022
  • Uses of Diazoxide
  • Diazoxide is a well-characterized low molecular weight (MW 230.7) drug that is a derivative of benzothiadiazine but that posse....
  • Jan 17,2022

DIAZOXIDE Spectrum

Eudemine DIAZOXIDE ACTIVATOR OF ATP-DEPE DIAZOXIDE,USP NSC-64198 Sch-6783 7-chloro-3-methyl-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide Diazoxide,7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide 2h-1,2,4-benzothiadiazine,7-chloro-3-methyl-,1,1-dioxide 7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine1 7-cloro-3-metil-2h-1,2,4-benzotiodiazina-1,1-diossido Diazoxide (200 mg) mutabase proglicem srg95213 7-CHLORO-3-METHYL-2H-1,2,4-BENZOTHIADIAZINE 1,1-DIOXIDE diazossido dizoxide 7-chloro-3-methyl-4H-1λ,2,4-benzothiadiazine-1,1-dione DIAZOXIDE Diazoxided DIAZOXIDE 364-98-7 kf-wang(at)kf-chem.com Diazoxide API 7-chloro-3-methyl-4h-1λ6,2,4-benzothiadiazine 1,1-dioxide 3-Methyl-7-chloro-1,2,4-benzothiadiazine 1,1-dioxide Diazoxide CRS DIAZOXIDE USP/EP/BP diazoxid Diazoxide-13CD3 Diazoxide (1186000) hyperstat Proglycem Desipramine Impurity 7 Diazoxide Benzothiadiazinone Analog Diazoxide impurity-4 (7-chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide) 364-98-7 C8H7ClN2O2S Ion Channels Monovalent Ion Channels Potassium Channel Modulators Voltage-gated Ion Channels BioChemical Cell Signaling and Neuroscience Cell Biology ALCLOXA Aromatics Intermediates & Fine Chemicals Pharmaceuticals Sulfur & Selenium Compounds Ion Channels Potassium channel API